Pharmaceutical Sciences News

Balthasar awarded $1.8 million grant to improve safety of cancer treatments
6/3/20
Joseph Balthasar, BS '91 & PhD '96, professor, pharmaceutical sciences, has received a new $1.8 million R01 grant from the National Cancer Institute (NCI) to develop strategies to improve the safety and efficacy of anti-cancer antibodies and antibody-drug conjugates.
UB is collaborating with Roswell Park on international clinical trial for COVID-19
4/2/20
UB and Roswell Park Comprehensive Cancer Center have launched a collaborative clinical trial that will make a new treatment option available to local patients diagnosed with COVID-19.
UB pharmacy ranked as a top 15 school
3/17/20
BUFFALO, N.Y. — The University at Buffalo School of Pharmacy and Pharmaceutical Sciences was ranked No.14 by U.S. News & World Report in its ranking of Doctor of Pharmacy (PharmD) schools and programs.
UB Department of Pharmaceutical Sciences enhances strengths in drug delivery and quantitative systems pharmacology with two new faculty
1/20/20
BUFFALO, N.Y.—The Department of Pharmaceutical Sciences recently welcomed two new faculty.
Study finds link between blood fats and artery size in people with MS
1/17/20
Researchers' aim was to determine the effect of a person’s blood lipids on the major arteries outside the skull.
Jun Qu co-PI on two new UB grants totaling more than $2 million
1/6/20
BUFFALO, N.Y. — UB is the recipient of a three-year, $1.2 million grant from the Department of Defense to develop effective therapeutic strategies that minimize the damaging effects of infection in chronic obstructive pulmonary disease (COPD).

Next> <Previous